OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of different PD ‐1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma
Zhengqing Lei, Weihu Ma, Anfeng Si, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 6, pp. 611-622
Closed Access | Times Cited: 9
Zhengqing Lei, Weihu Ma, Anfeng Si, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 6, pp. 611-622
Closed Access | Times Cited: 9
Showing 9 citing articles:
Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 5
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 5
Current Trends and Innovative Approaches in Cancer Immunotherapy
Jae-Chang Kim, Ruby Maharjan, Jonghyuck Park
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 4
Jae-Chang Kim, Ruby Maharjan, Jonghyuck Park
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 4
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis
Yue Hu, Xiongying Jiang, Xi Cai, et al.
Journal of Gastrointestinal Oncology (2025) Vol. 16, Iss. 1, pp. 209-225
Open Access
Yue Hu, Xiongying Jiang, Xi Cai, et al.
Journal of Gastrointestinal Oncology (2025) Vol. 16, Iss. 1, pp. 209-225
Open Access
Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
Yan Ou, Shufang Liang, Qiangqiang Gao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Yan Ou, Shufang Liang, Qiangqiang Gao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinoma
Qin Liu, Yuanyuan Chen, Yan Hu, et al.
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100771-100771
Open Access | Times Cited: 2
Qin Liu, Yuanyuan Chen, Yan Hu, et al.
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100771-100771
Open Access | Times Cited: 2
Editorial: Advances in immunotherapy and combination therapy for biliary tract cancers
Chengpei Zhu, Simon C. Robson, Hui‐Chuan Sun, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access
Chengpei Zhu, Simon C. Robson, Hui‐Chuan Sun, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access
The fibrosis-4 index is a prognostic factor for cholangiocarcinoma patients who received immunotherapy
Zhiwei Zhang, Jingzhao Zhang, Ming Cai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Zhiwei Zhang, Jingzhao Zhang, Ming Cai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Clinical outcomes of immune checkpoint inhibitor combined with other targeted or immunological therapy regimens for the treatment of advanced bile tract cancer: a systematic review and meta-analysis
Jianpeng Zhou, Jia Li, Zhongqi Fan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jianpeng Zhou, Jia Li, Zhongqi Fan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort study
Zhipeng Sun, Hai Xu, Lei Yang, et al.
BioScience Trends (2024) Vol. 18, Iss. 6, pp. 599-609
Open Access
Zhipeng Sun, Hai Xu, Lei Yang, et al.
BioScience Trends (2024) Vol. 18, Iss. 6, pp. 599-609
Open Access
